Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine

Forensic Science International

Volumn 188, Issue 1-3, 2009, Pages 131-139

  Zaitsu, Kei ^a   Katagi, Munehiro ^a   Kamata, Hiroe T ^a   Kamata, Tooru ^a   Shima, Noriaki ^a   Miki, Akihiro ^a   Tsuchihashi, Hitoshi ^a   Mori, Yasushige ^b  

^a Chuo ward   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

bk MBDB; bk MDEA; Designer drug; Metabolism

Indexed keywords

2 BUTANONE; 2 METHYLAMINO 1 (3,4 METHYLENEDIOXYPHENYL)BUTAN 1 ONE; DESIGNER DRUG; KETONE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DEALKYLATION; FEMALE; HUMAN; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITE; METHYLATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; URINALYSIS;

3,4-METHYLENEDIOXYAMPHETAMINE; DESIGNER DRUGS; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALLUCINOGENS; HUMANS; HYDROLYSIS; METHYLATION;

EID: 67349215762     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.04.001     Document Type: Article

References (19)

1. Cozzi N.V., Sievert M.K., Shulgin A.T., Jacob P., and Ruoho A.E. Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one (methylone) selectively inhibit plasma membrane monoamine transporters. Soc. Neurosci. Abstr. 24 (1998) 381.8
2. Cozzi N.V., Sievert M.K., Shulgin A.T., Jacob P., and Ruoho A.E. Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Eur. J. Phamacol. 381 (1999) 63-69
3. Brenneisen R., Fisch H.U., Koelbing U., Geisshusler S., and Kalix P. Amphetamine-like effects in human of the khat alkaloid. Br. J. Clin. Phamacol. 30 (1990) 825-828
4. Rothman R.B., Vu N., Partilla J.S., Roth B.L., Hufeisen S.J., Compton-Toth B.A., Birkes J., Young R., and Glennon R.A. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J. Pharmacol. Exp. Ther. 307 (2003) 138-145
5. Kamata H.T., Shima N., Zaitsu K., Kamata T., Miki A., Nishikawa M., Katagi M., and Tsuchihashi H. Metabolism of the recently encountered designer drug, methylone in humans and rats. Xenobiotica 36 8 (2006) 709-723
6. Shima N., Katagi M., Kamata H., Zaitsu K., Kamata T., Nishikawa M., Miki A., Tsuchihashi H., Sakuma T., and Nemoto N. Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats. Xenobiotica 38 3 (2008) 314-324
7. Zaitsu K., Katagi M., Kamata H.T., Miki A., and Tsuchihashi H. Discrimination and identification of regioisomeric β-keto analogues of 3,4-methylenedioxyamphetamine by gas chromatography-mass spectrometry. Forensic Toxicol. 26 (2008) 45-51
8. Shima N., Kamata H., Katagi M., Tsuchihashi H., Sakuma T., and Nemoto N. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine. J. Chromatogr. B 857 (2007) 123-129
9. Zaitsu K., Katagi M., Kamata T., Kamata H., Shima N., Tsuchihashi H., Hayashi T., Kuroki H., and Matoba R. Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine and blood. Forensic Sci. Int. 177 (2008) 77-84
10. Testa B., and Beckett A.H. Metabolism and excretion of diethylpropion in man under acidic urine conditions. J. Pharm. Pharmacol. 25 (1973) 119-124
11. Milhailova M., Rosen A., Testa B., and Beckett A.H. A pharmacokinetic investigation of the distribution and elimination of diethylpropion and its metabolites in man. J. Pharm. Pharmacol. 26 (1974) 711-721
12. Brenneisen R., Geisshusler S., and Schormo H. Metabolism of cathinone to (-)-norephedrine and (-)-norpseudoephedrine. J. Pham. Pharmacol. 38 (1986) 298-300
13. Brenneisen R., Mathys K., and Geisshusler S. Determination of S-(-)-cathinone and its main metabolite R, S-(-)-norephedrine in human plasma by high-performance liquid chromatography and photodiode array detection. J. Liq. Chromatogr. 14 (1991) 271-286
14. Paul B.D., and Cole K.A. Cathinone (Khat) and methacathinone (CAT) in urine specimens: a gas chromatographic-mass spectrometric detection procedure. J. Anal. Toxicol. 25 (2001) 525-530
15. Toennes S.W., and Kauert G.F. Excretion and detection of cathinone, cathine, and phenylpropanolamine in urine after kath chewing. Clin. Chem. 48 (2002) 1715-1719
16. Zaitsu K., Katagi M., Kamata H., Kamata T., Shima N., Miki A., Iwamura T., and Tsuchihashi H. Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS). J. Mass Spectrom. 43 (2008) 528-534
17. Morita M., and Ando H. Analysis of methamphetamine and its metabolites in urine from a harbitual user of the stimulant. EISEI KAGAKU 29 (1983) 318-322 (in Japanese)
18. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man. Sixth ed. (2002), Biomedical Publications, Forester City, CA p. 687
19. Marakantonis S.L., Kyroudis A., and Beckett A.H. The stereoselective metabolism of dimethylpropion and monomethylpropion. Biochem. Pharamacol. 35 (1986) 529-532